Connect with us

Business

Eminent Lawyer & Educationist D.C. Singhania awarded Time Magazine India Life time achievement award 2021

blank

Published

on

blank

New Delhi [India], November 25 (ANI/Heylin Spark): On Sunday, 21 November 2021, Time Magazine India organized Time Magazine Excellence Iconic Awards 2021at Suryaa Hotel, New Delhi, in which D.C. Singhania an eminent lawyer and founder of Singhania and Company was felicitated by Life time achievement award 2021.

In the award ceremony, many prominent people were felicitated in various fields like journalism, health, education and social work. The event also hosted the book launch of 3rd Edition of Mass Communication: Principles and Concepts authored by Seema Hasan.

Other than felicitation, three Honorary Doctorate degrees were awarded to Md. Ameen (Former Diplomat in Govt. of India), M.K Chishty (Head priest Sufi saint at World Atodra Dargah Sharif, Olpad, Surat), and Mr. AtyabSiddqiui (Senior advocate at Supreme Court & Delhi high court) from Royal American University.

Also, the event hosted various performances by National Institute of Mass Communication students, professional singers and dancers to display their skills in art and culture.

This story is provided by Heylin Spark. ANI will not be responsible in any way for the content of this article. (ANI/Heylin Spark)

DISCLAIMER

(This story has not been edited by PRESS24 NEWS staff and is auto-generated from a syndicated feed.)

 

Dear Reader,

PRESS24 NEWS has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to PRESS24 NEWS.

Digital Editor


Disclaimer: This post has been auto-published from an agency/news feed without any modifications to the text and has not been reviewed by an editor.

Source link

Business

Delhi Assembly’s peace & harmony committee summons Kangana Ranaut over social media posts

blank

Published

on

blank


Delhi Assembly’s peace and harmony committee has summoned Bollywood actor Kangana Ranaut over her alleged hateful posts on social media, panel chairperson Raghav Chadha said on Thursday.


The committee issued a notice to Ranaut summoning her on December 6 over complaints citing an alleged offensive and derogatory Instagram story posted by her, said a statement from the panel.





The complaints claimed that Ranaut, in her story, labelled the Sikh community ‘Khalistani terrorists’.

(Only the headline and picture of this report may have been reworked by the PRESS24 NEWS staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

PRESS24 NEWS has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to PRESS24 NEWS.

Digital Editor


Disclaimer: This post has been auto-published from an agency/news feed without any modifications to the text and has not been reviewed by an editor.

Source link

Continue Reading

Business

GSK Pharma surges 11%, hits 52-week high on improved outlook

blank

Published

on

blank

Shares of GlaxoSmithKline Pharmaceuticals (GSK Pharma) hit a fresh 52-week high at Rs 1,797, on ralling 11 per cent on the BSE in Thursday’s intra-day trade on improved business outlook. The stock of the drug maker has surpassed its previous high of Rs 1,766 touched on July 27, 2021. It had hit a record high of Rs 1,925 on March 31, 2016.


In the past one month, GSK Pharma has outperformed the market by surging 22 per cent, after the company reported a strong set of numbers for the quarter ended September 2021 (Q2FY22). In comparison, the S&P BSE Sensex was down 4 per cent.





In Q2FY22, the company’s standalone profit before tax or PBT (before exceptional) grew 42 per cent year on year (YoY) to Rs 271 crore from Rs 191 crore in a year ago quarter. Revenue grew 13 per cent YoY at Rs 992 crore. Earnings before interest, taxes, depreciation, and amortization (ebitda) margin improved 430 basis point to 27.62 per cent from 23.32 per cent in Q2FY21.


The management expects this positive momentum to continue through the second half of the year driving the company towards the better end of a meaningful performance improvement.


As the acute market showed signs of recovery, the company’s established brands grew in their respective therapeutic portfolios. Augmentin and Calpol regained their place amongst the top five brands in the Indian Pharmaceuticals Market (1PM). “Our promoted portfolio also gained market share, while products from our innovation and specialty pipeline continued to make inroads to serve more patients,” the management said.

Dear Reader,

PRESS24 NEWS has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to PRESS24 NEWS.

Digital Editor


Disclaimer: This post has been auto-published from an agency/news feed without any modifications to the text and has not been reviewed by an editor.

Source link

Continue Reading

Business

Latest News: India News | Latest Business News | BSE

blank

Published

on

blank


Disclaimer: This post has been auto-published from an agency/news feed without any modifications to the text and has not been reviewed by an editor.

Source link

Continue Reading

Trending